Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Metformin is less effective in men with early-onset hair loss.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Cold-pressed rapeseed oil is most resistant to oxidation and certain oils may reduce chronic disease risk; consumers like the taste of pumpkin oil best.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Early hair loss may predict heart disease.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Healthy diet and exercise are important for women with PCOS to manage weight and metabolic issues, and supplements like omega-3, vitamin D, and inositol may help.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Anabolic-androgenic steroids increase the risk of heart problems.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Minoxidil and nebivolol can help prevent aortic aging in diabetic mice.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.